NetworkNewsBreaks

ThursdayMay 07, 2020 12:11 pm

NetworkNewsBreaks – iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) to Report Q1 2020 Financial Results, Host Conference Call

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it will report its unaudited first quarter 2020 financial results before the U.S. market opens on Friday, May 22, 2020. According to the update, the company's management team will host a conference call at 8:00 AM ET (8:00 PM Hong Kong Time) on May 22 to discuss its business and financial performance. Interested parties may participate by dialing +1-888-346-8982 (United States), +1-412-902-4272 (International), +852-800-905945 (Hong Kong), or +86-4001-201203 (Mainland China) and asking to join the iClick Interactive Asia Group Limited…

Continue Reading

ThursdayMay 07, 2020 12:05 pm

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Appointment of Personal Care Industry Leader as CEO to Lead Rebranded Company

Pressure BioScience (OTCQB: PBIO) today announced the appointment of personal care industry leader Jim Morrison to serve as the new CEO of the rebranded public company, with intended corporation name of Availa Bio, upon completion of the merger with Cannaworx, SkinScience Labs and Pressure BioSciences. Morrison’s career includes numerous leadership positions in the personal care industry, most notably as President of L'Oréal where he oversaw growth that averaged more than 20% year-over-year. In addition, Morrison engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth. “Jim is one of the preeminent beauty and…

Continue Reading

ThursdayMay 07, 2020 11:10 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces At-The-Market Priced $2.2M Registered Direct Offering

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its entry into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 1,396,826 shares of its common stock. According to the update, the shares are each $1.575, in a registered direct offering priced at-the-market under Nasdaq rules, for gross proceeds of approximately $2.2 million. In addition, Predictive Oncology has agreed to issue to the investors unregistered warrants to purchase up to an aggregate of 1,396,826 shares of common stock. Subject to…

Continue Reading

ThursdayMay 07, 2020 11:03 am

NetworkNewsBreaks – Cannabis Global, Inc. (MCTC) Enters Strategic Agreement with RxLeaf.com

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced a new marketing and informational agreement with the medical cannabis online media company RXLeaf.com. Under the agreement, RXLeaf will market various Cannabis Global products under its respective brands as well as under Cannabis Global’s Hemp You Can Feel(TM) branding. The agreement will put MCTC’s products in front of thousands of RxLeaf's online members, with visitors that include doctors, patients, researchers, advocates, and distributors. “We are honored to soon have our products featured on the RXLeaf website,” Arman Tabatabaei, CEO of Cannabis Global,…

Continue Reading

ThursdayMay 07, 2020 10:14 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Secures Health Canada Approval for Totality of Valleyfield Hybrid Greenhouse

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today announced its receipt of Health Canada's approval for the totality of its main Valleyfield hybrid greenhouse. According to the update, TGOD has the flexibility, with all twenty-four zones now licensed, to quickly expand its operations at Valleyfield as the market develops. The company also plans to leverage parts of the newly licensed space to shift a portion of its processing activities currently being handled at Ancaster or intended to be outsourced to third parties. This will assist the company in optimizing costs, accelerating…

Continue Reading

ThursdayMay 07, 2020 9:33 am

NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Hosting Conference Call, Webcast to Discuss Audited Q4 and Full Year 2019 Results

Plus Products (CSE: PLUS) (OTCQX: PLPRF) on Wednesday announced that after markets close on Thursday, May 7, the company will report its audited financial results for the fourth quarter and full year ending December 31, 2019. In addition, the company will also be hosting a conference call and webcast to discuss the financial results and recent corporate highlights on May 7 at 5 PM ET. Plus co-founder and CEO Jake Heimark and chief financial officer Jon Paul will also be conducting a question and answer session on the call. To join the call, dial (866) 220-4156 for the US and…

Continue Reading

ThursdayMay 07, 2020 8:30 am

NetworkNewsBreaks – NeoVolta Inc. (NEOV) Continues Providing Solar Storage Systems During Coronavirus

Due to its crucial role in providing emergency power for homeowners, NeoVolta (OTCQB: NEOV) is continuing to provide solar energy storage systems for Southern California during the coronavirus. The company partners with installation companies that have highly trained technicians implementing all possible health precautions. “We take the COVID-19 pandemic very seriously, and we are closely monitoring the situation and the appropriate medical advice,” NeoVolta CEO Brent Willson stated in the news release. “Homeowners in Southern California can be assured that NeoVolta and its authorized installers will continue to provide world-class service. Our primary goal will always be to keep our…

Continue Reading

WednesdayMay 06, 2020 12:37 pm

NetworkNewsBreaks – Immunic, Inc. (NASDAQ: IMUX) Secures $15M in Registered Direct Offering

Immunic (NASDAQ: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, has closed a sale of 1,764,706 shares of common stock with certain institutional investors, led by Altium Capital. According to the update, Immunic secured approximately $15 million in gross proceeds, with each of the shares sold at a price of $8.50. Immunic intends to use the proceeds to fund the ongoing clinical development of its three small molecule products: IMU-838, IMU-935 and IMU-856, as well as for other general corporate purposes, including to investigate its lead asset, IMU-838,…

Continue Reading

WednesdayMay 06, 2020 12:33 pm

NetworkNewsBreaks – Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) Secures $20M in Public Offering

Cyclacel Pharmaceuticals (NASDAQ: CYCC), a biopharmaceutical company developing innovative medicines based on cancer cell biology, has closed a public offering of (i) 4,000,000 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and (ii) common warrants to purchase up to 4,000,000 shares of common stock. According to the update, each share of common stock and, as applicable, each pre-funded warrant, was sold together with a common warrant to purchase one share of common stock at a combined effective price to the public of $5.00 per share and accompanying common warrant, and/or $4.999 per pre-funded…

Continue Reading

WednesdayMay 06, 2020 11:55 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Collaborates with Dr. Daniel Carter to Enter Race to Develop Potential COVID-19 Vaccine

Predictive Oncology (NASDAQ: POAI) has entered the race to develop a COVID-19 vaccine with the announced acquisition of Soluble Therapeutics, Inc. and the subsequent partnership and licensing of a novel nanoparticle vaccine platform recently developed by Dr. Daniel Carter. According to the update, the groundbreaking vaccine technology being developed by Dr. Carter is based on a self-assembling nanoparticle called NSP-10 (NSP is Non Specific Protein), which follows a foundational vaccine platform developed earlier by Dr. Carter and his team, using another self-assembling protein called ferritin (1), an iron storage protein found in all living things. NIH is currently exploiting the…

Continue Reading